Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: Involvement of opioid receptors and reactive oxygen species

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 322-331

  Tsao, Li I ^b   Ladenheim, Bruce ^b   Andrews, Anne M ^b   Chiueh, Chuang C ^b   Cadet, Jean Lud ^b   Su, Tsung Ping ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GLUTATHIONE; METHAMPHETAMINE; NALTREXONE; OPIATE RECEPTOR; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MOUSE; NERVE CELL MEMBRANE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BODY TEMPERATURE; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENKEPHALIN, LEUCINE-2-ALANINE; GLUTATHIONE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; MICE; NALTREXONE; NERVE TISSUE PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID;

EID: 0032454974     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Albers DS and Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275:1104-1114.
2. Ali SF, Newport GD, Robert Holson R, Slikker, W Jr and Bowyer JF (1994) Low-environmental temperature or pharmacological agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
3. 3-MPTP and MPTP. J Neurochem 60:1167-1170.
4. Appelbaum BD and Holtzman SG (1986) Stress-induced changes in the analgesic and thermic effects of opioid peptides in the rat. Brain Res 377:330-336.
5. Atlante A, Gagliardi S, Minervini GM, Ciotti MT, Marra E and Calissano P (1997) Glutamate neurotoxicity in rat cerebellar granule cells: A major role for xanthine oxidase in oxygen radical formation. J Neurochem 68:2038-2045.
6. Bai M (1997) White Storm Warning. Newsweek (March 31) 66-67.
7. Banks WA and Kastin AJ (1990) Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol 259:E1-10.
8. Benfenati F, Pich EM, Zoli M, Grimaldi R, Fuxe K and Agnati LF (1991) Changes in striatal μ and δ opioid receptors after transient forbrain ischemia: A quantitative autoradiographic study. Brain Res 546:171-175.
9. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 47:779-786.
10. Bolling SF, Su T-P, Childs KF, Ning X-H, Horton N, Kilgore K and Oeltgen PR (1997) The use of hibernation induction triggers for cardiac transplant preservation. Transplantation 63:326-329.
11. Bowyer JF, Davis DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, Robert Holson R (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
12. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E and Epstein CJ (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurosci 62:380-383.
13. Cappon GD, Broening HW, Pu C, Morford L and Vorhees CV (1996) alpha-Phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24:173-181.
14. Chien SF, Oeltgen PR, Diana JN, Salley RK and Su T-P (1994) Extension of tissue survival time in multiorgan block preparation using a delta opioid DADLE. J Thorac Cardiovasc Surg 107:964-967.
15. +. Free Rad Biol Med 13:581-583.
16. Feigenbaum JJ, Yanai J, Iser C and Klawans H (1984) Effect of naloxone on dopamine uptake and release in vitro in the striatum. Neuropsychobiology 11:94-97.
17. Haavik J, Almas B and Flatmark T (1997) Generation of reactive oxygen species by tyrosine hydroxylase: A possible contribution to the degeneration of dopaminergic neurons. J Neurochem 68:328-332.
18. Haberstock H and Marotti T (1995) The relevance of intact enkephalin moleculae in predominantly delta opioid receptor mediated superoxide anion release. Neuropeptides 29:357-365.
19. Hess KM and Dix TA (1992) Evaluation of N-hydroxy-2-thiopyridone as a nonmetal dependent source of hydroxyl radical in aqueous system. Anal Biochem 206:309-314.
20. Hirata H, Ladenheim BN, Carlson E, Epstein C and Cadet JL (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95-103.
21. Hirayama O and Yida M (1997) Evaluation of hydroxyl radical-scavenging ability by chemiluminescence. Anal Biochem 251:297-299.
22. Hurd YL and Herkenham M (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 16:97-104.
23. Jiang ZG and North RA (1992) Pre- and postsynaptic inhibition by opioids in rat striatum. J Neurosci 12:356-361.
24. Johnson SW and North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
25. Kastin AJ, Nissen C, Schally AV, Coy DH (1976) Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Res Bull 1:583-589.
26. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
27. Matsubara C, Nishikawa Y, Yoshida Y and Takamura K (1983) A spectrophotometric method for the determination of free fatty acid in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase. Anal Biochem 130:128-133.
28. Mayfield KP and D'Alecy LG (1994) Delta-1 opioid receptor dependence of acute hypoxic adaptation. J Pharmacol Exp Ther 268:74-77.
29. Mohannakumar KP, de Bartolomeis A, Wu RM, Yeh KJ, Sternberg LM, Peng SY, Murphy DL and Chiueh CC (1994) Ferrous-citrate complex and nigral degeneration: Evidence for free-radical formation and lipid peroxidation. Ann NY Acad Sci 738:392-399.
30. Nourooz-Zadeh J, Tajaddini-Sarmadi J and Wolff SP (1994) Measurement of plasma hydroperoxide concentration by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403-409.
31. O'Callaghan JP and Miller DB (1994) Neurotoxicity profile of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751.
32. Ododeo-Sale F, Gramingna D and Campaniello R (1997) Lipid peroxidation and antioxidant systems in rat brain: Effect of chronic alcohol consumption. Neurochem Res 22:577-582.
33. Oeltgen PR, Nuchols PA, Nilekani WA, Spurrier WA and Su T-P (1988) Further studies on opioids and hibernation: Delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci 43:1565-1574.
34. Oeltgen PR, Horton ND, Bolling SF and Su T-P (1996) Extended lung preservation with the use of hibernation trigger factors. Ann Thorac Surg 61:1488-1493.
35. Petit F, Mamon M, Fournie-Zaluski MC and Roques BP (1986) Further evidence for a role of delta opiate receptor in the presynaptic regulation of newly synthesized dopamine release. Eur J Pharmacol 126:1-9.
36. 3H]tyrosine by charcoal. Life Sci 39:2185-2189.
37. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR and Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res 235:93-103.
38. Roubaud V, Sankarapandi S, Kuppusamy P, Tordo P and Zweier JL (1997) Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphory)-5-,methyl-1-pyrroline-N-oxide. Anal Biochem 247:404-411.
39. Schad CA, Justice JB Jr and Holtzman SG (1996) Differential effects of δ- and μ-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 67:2292-2299.
40. Schlösser B, Kudernatsch MB, Sutor B and ten Bruggencate G (1995) Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat striatal slices. Neurosci Lett 191:126-130.
41. Seiden LS, Fischman MW and Schuster CR (1975) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219.
42. Seiden LS and Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol Biochem Behav 21:29-31.
43. Sonsalla PK, Riordan DE and Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256:506-512.
44. Vrana SL, Azzaro AJ and Vrana KE (1992) Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway. Mol Pharmacol 41:839-844.
45. Walsh SL and Wagner GC (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 263:617-626.
46. Wilson JM, Kalasinsky KS, Levey AI, Begeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW and Kish SJ (1996) Striatal dopamine nerve terminal markers in human chronic methamphetamine users. Nature Med 2:699-703.
47. Woolverton WL, Ricaurte GA, Forno LS and Seiden LS (1989) Long term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486:73-78.
48. Wu G, Zhang F, Salley RK, Diana JN, Su T-P and Chien S (1996) Delta opioid extends hypothermic preservation time of the lung. J Thorac Cardiovasc Surg 111:209-267.